摘要
目的本研究旨在探讨2型糖尿病不同程度肾病与chemerin、SOD及MDA的相关性。方法选取2016年1月—2017年12月期间于广州市第一人民医院内分泌科门诊和住院的患者100例,根据尿白蛋白/肌酐比(ACR)分为正常尿蛋白组(NA组,n=33),微量白蛋白尿组(MA组,n=34)及大量蛋白尿组(CA组,n=33),另选取32例我院体检中心体检结果正常的正常健康人作为对照组(NC组,n=32),测定血糖、糖化血红蛋白、血肌酐、ACR、24小时尿蛋白定量、胆固醇、甘油三酯、SOD、MDA、chemerin等水平。结果 SOD的水平:NC组> NA组> MA组>CA组(P<0.05);MDA的水平:CA组>MA组>NA组>NC组(P<0.05);Chemerin水平:CA组>MA组>NA组>NC组(P<0.05)。相关性分析提示ACR与血清SOD呈负相关,与MDA、chemerin呈正相关。多元回归分析显示,病程、胆固醇、糖化血红蛋白、chemerin是影响ACR的主要因素。结论 Chemerin、MDA、SOD可能参与糖尿病肾病的发生发展,检测其水平可以在一定程度上反映2型糖尿病肾病患者的病情严重程度。
Objective To explore the relationship between different type of Type 2 diabetes nephropathy and chemerin,SOD,MDA. Methods A total of 100 inpatients and outpatients were enrolled in this study between January 2016 and December 2017 in Guangzhou First People s Hospital. They were divided into normal urinary protein group (NA group, n =33), microalbuminuria group (MA group, n =34) and massive proteinuria group (CA group, n =33) based on ACR. Another 32 healthy people were collected as a control group in medical examination center (NC group, n =32). The levels of blood sugar, glycated hemoglobin, serum creatinine, ACR, 24-hour urinary protein, cholesterol, triglyceride, SOD, MDA and chemerin were measured. Results The level of SOD: NC group > NA group > MA group > CA group ( P < 0.05). The level of MDA: CA group > MA group > NA group > NC group ( P < 0.05). The level of chemerin: CA group > MA group > NA group > NC group ( P < 0.05). Correlation analysis showed that ACR was negatively correlated with serum SOD and positively correlated with MDA and chemerin. Multivariate logistic regression demonstrated that course of disease, CHOL, HbA1c and chemerin were the main factors affecting ACR. Conclusion Chemerin, MDA and SOD may be involved in the occurrence and development of diabetic nephropathy. Chemerin, MDA and SOD may reflect the severity of type 2 diabetic nephropathy.
作者
卢建文
银孟卓
LU Jianwen;YIN Mengzhuo(Guangzhou First People's Hospital,Guangzhou 510180,China)
出处
《广州医药》
2019年第2期7-10,共4页
Guangzhou Medical Journal
基金
广州市卫生和计划生育科技项目(20181A011009)
关键词
糖尿病肾病
CHEMERIN
SOD
MDA
Diabetic nephropathy
Chemerin
Superoxidedismutase (SOD)
Malondiadehyde (MDA)